BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: L'Heveder A, Jones BP, Saso S, Barcroft J, Richardson R, Kaur B, Ghaem-Maghami S, Yazbek J, Smith JR. Conservative management of uterine adenosarcoma: lessons learned from 20 years of follow-up. Arch Gynecol Obstet 2019;300:1383-9. [PMID: 31584132 DOI: 10.1007/s00404-019-05306-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li JY, Mutlu L, Tymon-Rosario J, Khadraoui W, Nagarkatti N, Hui P, Buza N, Lu L, Schwartz P, Menderes G. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecol Oncol Rep 2022;39:100913. [PMID: 35005157 DOI: 10.1016/j.gore.2021.100913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Watrowski R, Ivanova Y, Slavchev S, Mitev D, Yordanov A. New Aspects of Sarcomas of Uterine Corpus-A Brief Narrative Review. Clin Pract 2021;11:878-900. [PMID: 34842646 DOI: 10.3390/clinpract11040103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Barinova IV, Voloshchuk IN, Fedorov AA, Puchkova NV, Buyanova SN, Chechneva MA, Popov AA, Kapitanova OV, Kondrikov NI. [Uterine adenosarcoma. Report of 5 cases and review of literature]. Arkh Patol 2021;83:25-32. [PMID: 33822551 DOI: 10.17116/patol20218302125] [Reference Citation Analysis]
4 Mocellin S. Uterine Adenosarcoma. Soft Tissue Tumors 2021. [DOI: 10.1007/978-3-030-58710-9_248] [Reference Citation Analysis]
5 Zizolfi B, Foreste V, Di Spiezio Sardo A, Manzi A, Bifulco G, Carugno J. Fertility sparing management of uterine adenosarcoma: Case report and literature review. Facts Views Vis Obgyn 2021;12:315-8. [PMID: 33575681] [Reference Citation Analysis]